Morgan Stanley »

Abcellera Biologics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.8M 390k 4.53
2023-09-30 $2.7M 581k 4.60
2023-06-30 $7.6M 1.2M 6.46
2022-12-31 $6.4M 636k 10.13
2022-06-30 $5.1M 479k 10.64
2022-03-31 $3.8M 393k 9.73
2021-06-30 $12M 574k 21.59
2020-12-31 $118k 3.0k 40.00